Literature DB >> 348347

A small dose of somatostatin inhibits the pentagastrin stimulated gastric secretion of acid, pepsin and intrinsic factor in man.

E Schrumpf, M H Vatn, K F Hanssen, J Myren.   

Abstract

The effect of a small dose of somatostatin (0.05 mg/h) on the gastric secretion of acid, pepsin and Intrinsic Factor (IF) after stepwise increases in the dose of pentagastrin was examined in six healthy volunteers. The gastric secretion of acid, pepsin and IF in response to pentagastrin was significantly reduced by a continuous infusion of somatostatin. The pattern of inhibition indicates that somatostatin is a competitive inhibitor of pentagastrin in the stimulation of gastric secretion of both acid, pepsin and IF. This finding supports the hypothesis of a direct effect of somatostatin on the exocrine secretory cells of the stomach.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348347     DOI: 10.1111/j.1365-2265.1978.tb02173.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial.

Authors:  T K Choi; F Mok; W H Zhan; S T Fan; E C Lai; J Wong
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

2.  Is somatostatin a humoral regulator of the endocrine pancreas and gastric acid secretion in man?

Authors:  F B Loud; J J Holst; E Egense; B Petersen; J Christiansen
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

3.  A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man.

Authors:  M H Vatn; E Schrumpf; K F Hanssen; J Myren
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

4.  Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage.

Authors:  I Magnusson; T Ihre; C Johansson; U Seligson; S Törngren; K Uvnäs-Moberg
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.